Navigation Links
Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
Date:3/24/2008

ZFN Technology has Broad Applications in Research, Drug Development and

Therapeutics

ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) and Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of data demonstrating the use of Sangamo's zinc finger DNA-binding protein nucleases (ZFNs(TM)) in a new approach for rapid generation of "knock-out" cell lines, important tools in research and therapeutic product development.

This work, which was carried out in collaboration with scientists from Pfizer Inc, represents a significant advance in the specificity and efficiency of the generation of cell lines in which an individual gene has been "knocked-out" or deleted. Such cell lines are powerful tools that are widely used in research to identify a gene's function, in drug development to screen potential drug candidates and for production of recombinant proteins. In addition, Sangamo is using this technology to develop ZFP Therapeutics(TM) for the treatment of HIV/AIDS and brain cancer. Sigma-Aldrich is Sangamo's exclusive licensee for this technology in the laboratory research reagent field.

"These data have broad implications for experimental and translational biology, biotechnology and medicine," said Philip Gregory, D.Phil., Sangamo's vice president of research. "The generation of knockouts in basic research and industrial cell line engineering has been severely limited by the absence of efficient
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
4. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
5. Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
6. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
7. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
8. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
9. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
10. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
11. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX, "Chindex" or ... in China through the ... private hospitals and affiliated ambulatory clinics, today announced ... Rehabilitation Hospital ("BJU Rehab Hospital"), one of the ... ("UFH") network. On June 19, 2013, the Company ...
(Date:6/19/2013)... , June 19, 2013 DST Health ... and services to health plans, integrated delivery systems, and ... Medical Drug Management Service (MDMS) has jumped ... edit and automate the pricing of medical prescription drug ... efficiencies by automating their medical drug claims processes. As ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
Breaking Medicine Technology:Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... Calif., Oct. 25 Applied Seals North ... products used in ultraclean manufacturing of nanoelectronics and ... capabilities at its Silicon Valley headquarters with the ... Chen joins the company,s product engineering team to ...
... EAST BRUNSWICK, N.J., Oct. 25 Savient Pharmaceuticals, Inc. (Nasdaq: ... process to identify, following the approval of KRYSTEXXA™ by the ... the sale of the Company did not result in a ... directors will continue to evaluate strategic alternatives available to the ...
Cached Medicine Technology:Applied Seals North America Bolsters Engineering and Applications Services in Silicon Valley With Addition of Design Engineer 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 2Savient Pharmaceuticals Provides Update on Strategic Alternatives Process 3
(Date:6/19/2013)... 2013 Daily Gossip issued a press release ... will be published on their website at the end ... to inform readers about the information they will find on ... working at Daily Gossip, the article is a review of ... Hiller has understood during the vast research he has performed ...
(Date:6/19/2013)... PrettySkin4Less announces it is stocking up with the ... skin care manufacturer EMINENCE to meet customer demands. These ... active organic ingredients to promote actual change rather than ... offer. For this reason it’s not hard to see ... products that do what they say they will and ...
(Date:6/19/2013)... UT (PRWEB) June 19, 2013 ... , In July 2013, Orriant is launching a ... rates, and maintain compliance with regulations. New ... to receive wellness incentives if their employer offers ... they have been compliant with these standards for ...
(Date:6/19/2013)... York, New York (PRWEB) June 19, 2013 ... pancreatitis and pancreatic cancer continue to mount in courts ... U.S. Food & Drug Administration (FDA) recently held a ... diabetes drugs known as incretin mimetics. According to ... seek additional data from the makers of Januvia and ...
(Date:6/19/2013)... what is believed to be the largest follow-up record ... dystonia a movement disorder that can cause crippling ... good success rates and lasting benefits. , Michele Tagliati, ... Cedars-Sinai Medical Center,s Department of Neurology, and Ron L. ... Beth Israel Deaconess Medical Center in Boston, published the ...
Breaking Medicine News(10 mins):Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Long-term study reports deep brain stimulation effective for most common hereditary dystonia 2
... for health care reform programs will result in the potential ... coverage in California, according to a new policy brief from ... The number represents approximately 20 percent of all uninsured children ... 40,000 may be eligible for coverage but may not apply, ...
... 2011) Autism Speaks, the world,s largest autism science ... for Autism have joined HP,s "Hacking Autism" initiative, which ... people with autism. "Hacking Autism" will crowd source ideas ... families and practitioners, and will engage developers and designers ...
... young adult mice that a lone brain stem cell is capable ... and glia important types of brain cells but also ... cells. A report on their study appears June 24 in ... has the capacity to generate both neurons, which send and receive ...
... , THURSDAY, June 30 (HealthDay News) -- Cotton swabs ... infections, according to researchers. Daily use of dry ... patients who,d undergone appendectomy dramatically reduced surgical site infections, ... underwent the daily routine developed infections, compared with 19 ...
... , THURSDAY, June 30 (HealthDay News) -- The number of ... levels has dropped by more than half over the past ... 6.3 per 100,000 in 2009, a new study reveals. ... decreased, the health effects from lead exposure are well characterized," ...
... the Sahlgrenska Academy, University of Gothenburg, have identified a ... The proteins, which carry specific sugar molecules, are found ... Alzheimer,s disease than in patients with dementia caused by ... treatment in the future. , Gran Larson is a ...
Cached Medicine News:Health News:Up to 220,000 California children excluded from health care reform due to immigrant status 2Health News:Autism Speaks and Flutie Foundation join HP's 'Hacking Autism' to develop touch apps for autism 2Health News:Autism Speaks and Flutie Foundation join HP's 'Hacking Autism' to develop touch apps for autism 3Health News:Nervous system stem cells can replace themselves, give rise to variety of cell types, even amplify 2Health News:Cotton Swabs Help Prevent Surgical Site Infections: Study 2Health News:On-the-Job Lead Exposures Falling, But Still a Problem: CDC 2Health News:New clues to the cause of Alzheimer's disease 2
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
Medicine Products: